Impedimed LimitedASX: IPD

FDA Clearance for Sarcopenia Risk Assessment Received

· Issued by ImpediMed Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/fda-clearance-for-sarcopenia-risk-assessment-received

Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call

Page | 1 ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: investorrelations@impedimed.com W: impedimed.com 19 August 2026 Companies Announcements Office Australian Securities Exchange SOZO ® Digital Health Platform Receives FDA Clearance for...

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Earlier from Impedimed

Later from Impedimed

All Impedimed news releases